BC-promoting action of obesity is undoubtedly multifactorial; among the factors contributing to BC progression under an obese state, most attention was attracted to increased circulating levels of insulin, glucose, inflammatory mediators, alterations in adipokine pathophysiology, and, in hormone-responsive BC subtypes, misbalanced estrogen production in adipose tissue [6]. The gene discussed is INS; the disease is obesity disorder.